293 related articles for article (PubMed ID: 23880482)
1. Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?
Tamagni C; Studerus E; Gschwandtner U; Aston J; Borgwardt S; Riecher-Rössler A
Psychiatry Res; 2013 Dec; 210(2):427-31. PubMed ID: 23880482
[TBL] [Abstract][Full Text] [Related]
2. [Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?].
Dimitri-Valente G; Rigucci S; Manfredi G; Girardi P; Ferracuti S
Riv Psichiatr; 2012; 47(6):465-78. PubMed ID: 23160107
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of neurological soft signs in first-episode early-onset psychosis.
Mayoral M; Bombín I; Castro-Fornieles J; González-Pinto A; Otero S; Parellada M; Moreno D; Baeza I; Graell M; Rapado M; Arango C
J Child Psychol Psychiatry; 2012 Mar; 53(3):323-31. PubMed ID: 22023091
[TBL] [Abstract][Full Text] [Related]
4. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
5. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
6. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness.
Whitty P; Clarke M; McTigue O; Browne S; Gervin M; Kamali M; Lane A; Kinsella A; Waddington J; Larkin C; O'Callaghan E
Schizophr Res; 2006 Sep; 86(1-3):110-7. PubMed ID: 16765029
[TBL] [Abstract][Full Text] [Related]
8. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.
Harrisberger F; Smieskova R; Egli T; Simon AE; Riecher-Rössler A; Fusar-Poli P; Papassotiropoulos A; Borgwardt S
Cell Physiol Biochem; 2018; 48(3):1201-1214. PubMed ID: 30045020
[TBL] [Abstract][Full Text] [Related]
9. [Neurological soft signs in early onset schizophrenia].
Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis.
Heitz U; Studerus E; Menghini-Müller S; Papmeyer M; Egloff L; Ittig S; Navarra A; Andreou C; Riecher-Rössler A
Early Interv Psychiatry; 2019 Jun; 13(3):582-588. PubMed ID: 29235240
[TBL] [Abstract][Full Text] [Related]
11. Neurological soft signs precede the onset of schizophrenia: a study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia.
Chan RCK; Cui HR; Chu MY; Zhang TH; Wang Y; Wang Y; Li Z; Lui SSY; Wang JJ; Cheung EFC
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):49-56. PubMed ID: 28761988
[TBL] [Abstract][Full Text] [Related]
12. Neurological soft signs in first episode psychosis among psychiatric hospital patients and its relationship with dimensions of psychopathology: A comparative study.
Nwiyi OK; Ohaeri JU; Jidda MS; Danjuma IA; Onu JU; Oriji SO; Uwakwe R
Niger Postgrad Med J; 2023; 30(3):183-192. PubMed ID: 37675694
[TBL] [Abstract][Full Text] [Related]
13. Neurological soft signs in obsessive-compulsive disorder: the effect of co-morbid psychosis and evidence for familiality.
Peng ZW; Xu T; Miao GD; He QH; Zhao Q; Dazzan P; Chan RC
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):200-5. PubMed ID: 22735396
[TBL] [Abstract][Full Text] [Related]
14. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
[TBL] [Abstract][Full Text] [Related]
15. Trajectory of neurological examination abnormalities in antipsychotic-naïve first-episode psychosis population: a 1 year follow-up study.
Lizano P; Dhaliwal K; Lutz O; Mothi SS; Miewald J; Montrose D; Keshavan M
Psychol Med; 2020 Sep; 50(12):2057-2065. PubMed ID: 31451118
[TBL] [Abstract][Full Text] [Related]
16. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
[TBL] [Abstract][Full Text] [Related]
17. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
18. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment.
Cuesta MJ; Peralta V; Zarzuela A; Calvo R; García M; Serrano F
Schizophr Res; 2002 Dec; 58(2-3):263-71. PubMed ID: 12409167
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental markers in different psychopathological dimensions of first episode psychosis: the ESPIGAS study.
Ruiz-Veguilla M; Cervilla JA; Barrigón ML; Ferrín M; Gutiérrez B; Gordo E; Anguita M; Brañas A; Fernández-Logroño J; Gurpegui M
Eur Psychiatry; 2008 Dec; 23(8):533-40. PubMed ID: 18585009
[TBL] [Abstract][Full Text] [Related]
20. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
